The brave new world of stem cell research dangles the exciting potential for a host of leading-edge treatments that may one day help cure debilitating diseases such as Alzheimer's and Parkinson's, maladies that today cannot ...
Apr 11, 2012
0
0
Mike Hossfeld unlocked a heavy black steel door to his home's gun safe, unveiling both modern and antique firearms, some dating from the early 1900s.
Oct 30, 2023
0
0
British pharmaceutical group GlaxoSmithKline said Friday it has settled a US lawsuit which had alleged heartburn drug Zantac caused cancer, but admitted no liability.
Jun 23, 2023
0
35
Today, the Society for Cardiovascular Angiography & Interventions (SCAI) released an official position statement aimed at providing recommendations to minimize the potential risks involved with medical proctoring. The document, ...
Mar 31, 2022
0
0
Pharmaceutical companies making COVID vaccines are largely protected legally in the event of harmful side effects, like blood clots that have been linked to jabs from AstraZeneca and Johnson & Johnson.
Apr 20, 2021
0
1
While some bystanders may fail to attempt CPR because they fear legal liability, the likelihood of facing litigation is higher for delaying or failing to intervene, according to preliminary research to be presented at the ...
Nov 11, 2019
0
0
More than three-fourths US neurosurgeons practice some form of defensive medicine—performing additional tests and procedures out of fear of malpractice lawsuits, reports a special article in the February issue of Neurosurgery, ...
Jan 30, 2015
0
10
The American College of Physicians (ACP) today released a policy paper on the medical liability crisis, which continues to have a profound effect on the medical system. "Medical Liability Reform—Innovative Solutions for ...
Apr 10, 2014
0
0
The expansion of health insurance accomplished under the Affordable Care Act may alter costs for several major types of liability insurance, although any such changes are likely to be modest, according to a new RAND Corporation ...
Apr 9, 2014
0
0
U.S. drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion in a deal that should allow the rapidly growing company to reduce its tax bill and boost its royalty stream.
Jul 29, 2013
0
0
